The authors reply
- PMID: 35870817
- DOI: 10.1016/j.kint.2022.04.044
The authors reply
Comment on
-
Early post-transplant recurrence of oxalate nephropathy in a patient with primary hyperoxaluria type 1, despite pretransplant lumasiran therapy.Kidney Int. 2022 Jan;101(1):185-186. doi: 10.1016/j.kint.2021.10.022. Kidney Int. 2022. PMID: 34991805 No abstract available.
-
The appearance of oxalate crystals in a kidney biopsy is no proof of post-transplant oxalate nephropathy in primary hyperoxaluria type 1.Kidney Int. 2022 Aug;102(2):446. doi: 10.1016/j.kint.2022.04.043. Kidney Int. 2022. PMID: 35870818 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
